Integral Derivatives’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$450K Sell
9,800
-46,000
-82% -$2.23M 0.01% 408
2017
Q4
$2.82M Buy
55,800
+4,400
+9% +$232K 0.06% 216
2017
Q3
$2.67M Sell
51,400
-9,188
-15% -$447K 0.05% 247
2017
Q2
$2.97M Buy
60,588
+224
+0.4% +$10.4K 0.06% 216
2017
Q1
$2.84M Buy
60,364
+4,488
+8% +$214K 0.05% 233
2016
Q4
$2.68M Buy
55,876
+27,938
+100% +$1.28M 0.05% 250
2016
Q3
$1.11M Sell
27,938
-7,293
-21% -$274K 0.02% 406
2016
Q2
$1.25M Sell
35,231
-44,319
-56% -$1.73M 0.03% 350
2016
Q1
$3.12M Buy
79,550
+70,125
+744% +$2.62M 0.1% 145
2015
Q4
$405K Sell
9,425
-1,795
-16% -$78.9K 0.01% 706
2015
Q3
$472K Sell
11,220
-22,440
-67% -$1.05M 0.01% 727
2015
Q2
$1.68M Buy
+33,660
New +$1.59M 0.05% 371
2014
Q4
Sell
-22,440
Closed -$1.07M 1479
2014
Q3
$1.07M Sell
22,440
-22,103
-50% -$1.07M 0.02% 678
2014
Q2
$2.21M Buy
44,543
+4,712
+12% +$220K 0.04% 382
2014
Q1
$1.87M Buy
39,831
+224
+0.6% +$10.3K 0.04% 437
2013
Q4
$1.9M Buy
+39,607
New +$1.78M 0.03% 516

Other funds holding MET

Integral Derivatives's MET Position: Q3 2017 in Review

Integral Derivatives sold out of MetLife (MET) in Q3 2017, closing a stake of 14,421 shares — an estimated $702K sold.

Integral Derivatives first reported a position in MET in Q4 2013 and held it in 10 quarters. The position peaked at $1.18M in Q4 2016. 985 funds tracked by Wall St. Rank hold MET as of Q3 2017.

  • Integral Derivatives reported no remaining MetLife position as of Q3 2017 after selling out during the quarter.
  • Integral Derivatives sold 14,421 MetLife shares in Q3 2017, an estimated $702K.
  • Integral Derivatives first reported a position in MetLife in Q4 2013 and held it in 10 quarters.
  • Integral Derivatives's MetLife position peaked at $1.18M in Q4 2016.
  • 985 funds tracked by Wall St. Rank held MetLife as of Q3 2017.

Based on Integral Derivatives's 13F filing for Q3 2017, filed 14 Nov 2017.